Objective  To investigate the clinical efficacy and safety of wentong guasha combined with herbal enema in the treatment of acute attack of chronic pelvic inflammatory disease.

Methods  From January 2023 to December 2024, patients with acute attack of chronic pelvic inflammatory disease diagnosed and treated at Foshan Women and Children Hospital Affiliated to Guangdong Medical University were selected and randomly divided into an experimental group and a control group. The control group received herbal enema therapy, while the experimental group received additional wentong guasha therapy on the basis of the control group’s treatment. Both groups were treated for two weeks. The clinical efficacy, safety outcomes, as well as visual analog scale (VAS) scores for pain and Pittsburgh Sleep Quality Index (PSQI) scores before treatment and after the 3rd and 7th days of treatment were compared between the two groups.

Results  A total of 120 patients were included, with 60 cases in each group. After treatment, the total effective rate was 90.00% in the experimental group and 76.67% in the control group, showing a statistically significant difference between the two groups (P<0.05). On the 3rd day of treatment, the VAS score of the experimental group was significantly lower than that of the control group (P<0.05). By the 7th day of treatment, both the VAS and PSQI scores of the experimental group were significantly lower than those of the control group (P<0.05). No adverse reactions were observed in either group.

Conclusion  Compared with herbal enema therapy, wentong guasha combined with herbal enema demonstrated more significant clinical efficacy in patients with acute attack of chronic pelvic inflammatory disease, markedly reduced pain scores, improved sleep quality, and showed good safety, indicating its potential value for clinical promotion and application.

1.Darville T. Pelvic inflammatory disease due to neisseria gonorrhoeae and chlamydia trachomatis: immune evasion mechanisms and pathogenic disease pathways[J]. J Infect Dis, 2021, 224(12 Suppl 2): S39-S46. DOI: 10.1093/infdis/jiab031.

2.Franco PN, García-Baizán A, Aymerich M, et al. Gynaecological causes of acute pelvic pain: common and not-so-common imaging findings[J]. Life (Basel), 2023, 13(10): 2025. DOI: 10.3390/life13102025.

3.Greydanus DE, Cabral MD, Patel DR. Pelvic inflammatory disease in the adolescent and young adult: an update[J]. Dis Mon, 2022, 68(3): 101287. DOI: 10.1016/j.disamonth.2021.101287.

4.Ross J, Guaschino S, Cusini M, et al. 2017 European guideline for the management of pelvic inflammatory disease[J]. Int J STD AIDS, 2018, 29(2): 108-114. DOI: 10.1177/0956462417744099.

5.Nielsen T, Bribiesca R, Whealon C. Acute pelvic pain: diagnosis and management of ruptured hemorrhagic ovarian cyst[J]. Nurse Pract, 2025, 50(2): 42-47. DOI: 10.1097/01.NPR.0000000000000275.

6.胡依, 余艳兰, 唐丽. 盆炎丸联合雷火灸治疗盆腔炎性疾病后遗症的随机对照试验[J]. 药物流行病学杂志, 2025, 34(2): 144-150. [Hu Y, Yu YL, Tang L. Penyan pill combined with thunder fire moxibustion in patients with sequelae of pelvic inflammatory disease: a randomized controlled trial[J]. Chinese Journal of Pharmacoepidemiology, 2025, 34(2): 144-150.] DOI: 10.12173/j.issn.1005-0698.202412060.

7.Woźniak PR, Stachowiak GP, Pieta-Dolińska AK, et al. Anti-phlogistic and immunocompetent effects of acupuncture treatment in women suffering from chronic pelvic inflammatory diseases[J]. Am J Chin Med, 2003, 31(2): 315-320. DOI: 10.1142/S0192415X03000990.

8.Liang Y, Gong D. Acupuncture for chronic pelvic inflammatory disease: a qualitative study of patients' insistence on treatment[J]. BMC Complement Altern Med, 2014, 14: 345. DOI: 10.1186/ 1472-6882-14-345.

9.Zhou M, Li C, Cheng M, et al. RETRACTED: Medical thermal effects and CT radiation image examination in the treatment of sequelae of chronic pelvic inflammatory disease with warm acupuncture therapy: a Meta-analysis[J]. Therm Sci Eng Prog, 2025, 57: 103149. https://doi.org/10.1016/j.tsep.2024.103149.

10.Yang W, Liu H lin, Lu S, et al. Acupoint catgut embedding for treatment of chronic pelvic pain due to the sequelae of pelvic inflammatory disease[J]. J Vis Exp, 2024, (207): 66438-66452. DOI: 10.3791/66438.

11.曾芷怡, 李珊珊, 叶佩仪, 等. 循经温通刮痧结合中药药透疗法对气虚血瘀型偏瘫患者痉挛的干预研究[J]. 内蒙古中医药, 2025, 44(4): 107-109. [Zeng ZY, Li SS, Ye PY, et al. Study on the intervention of spasm in patients with hemiplegia of qi deficiency and blood stasis type by Wentong scraping along meridians combined with traditional Chinese medicine penetration therapy[J]. Inner Mongolia Chinese Medicine, 2025, 44(4): 107-109.] DOI: 10.16040/j.cnki.cn15-1101.2025.04.066.

12.叶金力, 梁瑞丽, 邢天伶, 等. 清热化湿逐瘀汤联合红藤方保留灌肠治疗慢性盆腔炎湿热瘀结证患者的疗效观察[J]. 世界中西医结合杂志, 2023, 18(2): 352-356, 362. [Ye JL, Liang RL, Xing TL, et al. Observation on the curative effect of Qingre Huashi Zhuyu decoction combined with Hongteng decoction retention enema in the treatment of patients with chronic pelvic inflammatory disease with damp-heat stasis syndrome[J]. World J Integr Med, 2023, 18(2): 352-356, 362.] DOI: 10.13935/j.cnki.sjzx.230225.

13.丰有吉, 沈鲣, 马丁, 等主编. 妇产科学, 第2版[M]. 北京: 人民卫生出版社, 2010: 218.

14.郑筱萸, 主编. 中药新药临床研究指导原则（试行）[M]. 北京: 中国医药科技出版社, 2002: 242-253.

15.Ranganathan P, Deo V, Pramesh CS. Sample size calculation in clinical research[J]. Perspect Clin Res, 2024, 15(3): 155-159. DOI: 10.4103/picr.picr_100_24.

16.卿璐芝, 高修安, 潘清洁, 等. 高修安辨治妇科病经验 [J]. 内蒙古中医药, 2020, 39(3): 76-78. [Qing LZ, Gao XA, Pan QJ, et al. Gao Xiuan's experience in treating gynecological diseases[J]. Inner Mongolia Chinese Medicine, 2020, 39(3): 76-78.] DOI: 10.16040/j.cnki.cn15-1101.2020.03.047.

17.Hartnett DA. Gua sha therapy in the management of musculoskeletal pathology: a narrative review[J]. Phys Ther Rev, 2022, 27(3): 169-175. https://doi.org/10.1080/10833196.2021.2011581.

18.Euasobhon P, Atisook R, Bumrungchatudom K, et al. Reliability and responsivity of pain intensity scales in individuals with chronic pain[J]. Pain, 2022, 163(12): e1184-e1191. DOI: 10.1097/j.pain.0000000000002692.

19.Backhaus J, Junghanns K, Broocks A, et al. Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia[J]. J Psychosom Res, 2002, 53(3): 737-740. DOI: 10.1016/s0022-3999(02)00330-6.

20.Dawood MY, Khan-Dawood FS, Wilson L. Peritoneal fluid prostaglandins and prostanoids in women with endometriosis, chronic pelvic inflammatory disease, and pelvic pain[J]. Am J Obstet Gynecol, 1984, 148(4): 391-395. DOI: 10.1016/0002-9378(84)90713-0.

21.Balogun JA, Okonofua FE. Management of chronic pelvic inflammatory disease with shortwave diathermy: a case report[J]. Phys Ther, 1988, 68(10): 1541-1545. https://pubmed.ncbi.nlm.nih.gov/2459722/.

22.Ma Y, Pei T, Song L, et al. Flavonoids from Smilax china L. rhizome improve chronic pelvic inflammatory disease by promoting macrophage reprogramming via the NLRP3 inflammasome-autophagy pathway[J]. J Funct Foods, 2023, 109: 105802. https://doi.org/10.1016/j.jff.2023.105802.

23.Liao C, Tan Y, Wang K, et al. The impact and correlation of anxiety and depression on pressure pain threshold of acupoints in patients with chronic pelvic inflammatory disease[J]. Pain Res Manag, 2023, 2023: 3315090. DOI: 10.1155/2023/3315090.

24.Marion T, Cao K, Roman J. Gua sha, or coining therapy[J]. JAMA Dermatol, 2018, 154(7): 788. DOI: 10.1001/jamadermatol.2018.0615.

25.Tsai KK, Wang CH. Acute epiglottitis following traditional Chinese gua sha therapy[J]. CMAJ, 2014, 186(8): E298. DOI: 10.1503/cmaj.130919.

26.Haggerty CL, Peipert JF, Weitzen S, et al. Predictors of chronic pelvic pain in an urban population of women with symptoms and signs of pelvic inflammatory disease[J]. Sex Transm Dis, 2005, 32(5): 293-299. DOI: 10.1097/01.olq.0000162361.69041.a5.

27.Zhang Z, Xie Z, Lyu S, et al. Integrated metabolomics and network pharmacology study on the mechanism of Kangfuxiaoyan suppository for treating chronic pelvic inflammatory disease[J]. Front Pharmacol, 2022, 13: 812587. DOI: 10.3389/fphar.2022.812587.